feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Evaxion: EVX-01 Ready to Start Phase II
Redeye comments on the regulatory clearance to start the planned phase II trial for the flagship product EVX-01 in combination with pembrolizumab.
RR
Richard Ramanius
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans